I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Beck, J. Thaddeus
99
results:
Search for persons
X
Format
Online (99)
Mediatypes
Articles (Online) (45)
OpenAccess-fulltext (54)
Sorted by: Relevance
Sorted by: Year
?
1
A Next-Generation BRAF Inhibitor Overcomes Resistance to BR..:
Yaeger, Rona
;
McKean, Meredith A.
;
Haq, Rizwan
...
Cancer Discovery. 14 (2024) 9 - p. 1599-1611 , 2024
Link:
https://doi.org/10.1158/..
?
2
Neoadjuvant talazoparib in patients with germline BRCA1/2 m..:
Telli, Melinda L.
;
Litton, Jennifer K.
;
Beck, J. Thaddeus
...
Breast Cancer. 31 (2024) 5 - p. 886-897 , 2024
Link:
https://doi.org/10.1007/..
?
3
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 M..:
Litton, Jennifer K
;
Beck, J Thaddeus
;
Jones, Jason M
...
The Oncologist. , 2023
Link:
https://doi.org/10.1093/..
?
4
A Phase Ib Study Assessing the Safety, Tolerability, and Ef..:
Bauer, Todd M.
;
Moore, Kathleen N.
;
Rader, Janet S.
...
Targeted Oncology. 18 (2023) 4 - p. 517-530 , 2023
Link:
https://doi.org/10.1007/..
?
5
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant ..:
Jerusalem, Guy
;
Delea, Thomas E.
;
Martin, Migule
...
Clinical Breast Cancer. 22 (2022) 4 - p. 326-335 , 2022
Link:
https://doi.org/10.1016/..
?
6
Safety and Efficacy of Dostarlimab in Patients With Recurre..:
Moreno, Victor
;
Roda, Desamparados
;
Pikiel, Joanna
...
Clinical Lung Cancer. 23 (2022) 7 - p. e415-e427 , 2022
Link:
https://doi.org/10.1016/..
?
7
Abemaciclib in Combination With Endocrine Therapy for Patie..:
Tolaney, Sara M.
;
Beeram, Muralidhar
;
Beck, J. Thaddeus
...
Frontiers in Oncology. 11 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
8
The Use of Patient-Reported Outcome Measures in Phase I Onc..:
Coleman, Robert L.
;
Beck, J. Thaddeus
;
Baranda, Joaquina C.
...
Oncology. 99 (2021) 7 - p. 444-453 , 2021
Link:
https://doi.org/10.1159/..
?
9
Abemaciclib in Combination With Pembrolizumab for Stage IV ..:
Pujol, Jean-Louis
;
Vansteenkiste, Johan
;
Paz-Ares Rodríguez, Luis
...
JTO Clinical and Research Reports. 2 (2021) 11 - p. 100234 , 2021
Link:
https://doi.org/10.1016/..
?
10
Safety and impact of dose reductions on efficacy in the ran..:
Burris, Howard A.
;
Chan, Arlene
;
Bardia, Aditya
...
British Journal of Cancer. 125 (2021) 5 - p. 679-686 , 2021
Link:
https://doi.org/10.1038/..
?
11
Myeloprotective Effects of Trilaciclib Among Patients with ..:
Hussein, Maen
;
Maglakelidze, Marina
;
Richards, Donald A
...
Cancer Management and Research. 13 (2021) - p. 6207-6218 , 2021
Link:
https://doi.org/10.2147/..
?
12
P10s-PADRE vaccine combined with neoadjuvant chemotherapy i..:
Makhoul, Issam
;
Ibrahim, Saddam Mohammed
;
Abu-Rmaileh, Muhammad
...
Oncotarget. 12 (2021) 22 - p. 2252-2265 , 2021
Link:
https://doi.org/10.18632..
?
13
Association of DNA-Methylation Profiles With Immune Respons..:
Hernandez Puente, Cinthia Violeta
;
Hsu, Ping-Ching
;
Rogers, Lora J.
...
Frontiers in Oncology. 10 (2020) - p. , 2020
Link:
https://doi.org/10.3389/..
?
14
Ribociclib plus fulvestrant for advanced breast cancer: Hea..:
Fasching, Peter A.
;
Beck, J. Thaddeus
;
Chan, Arlene
...
The Breast. 54 (2020) - p. 148-154 , 2020
Link:
https://doi.org/10.1016/..
?
15
Myelopreservation with Trilaciclib in Patients Receiving To..:
Hart, Lowell L.
;
Ferrarotto, Renata
;
Andric, Zoran G.
...
Advances in Therapy. 38 (2020) 1 - p. 350-365 , 2020
Link:
https://doi.org/10.1007/..
1-15